← Back
$MDGL All transactions

MADRIGAL PHARMACEUTICALS, INC.

▼ SELL 10b5-1 Plan

$ Value

$2.6M

Shares

6,485

Price

$400

Filed

Aug 21

Insider

Name

Sibold William John

Title

President and CEO

CIK

0001518611

Roles

Director Officer

Transaction Details

Transaction Date

2025-08-21

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

110,884

Footnotes

These sales were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $400.00 to $400.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnote below. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $401.00 to $401.01, inclusive.

Filing Info

Accession No.

0001518611-25-000007

Form Type

4

Issuer CIK

0001157601

Sibold William John's History

Date Ticker Type Value
2025-09-09 MDGL $3.2M
2025-08-21 MDGL $2.6M
2025-08-21 MDGL $454K

Other Insiders at MDGL (90d)

No other insider activity at this issuer in the last 90 days.